Congo health minister resigns over Ebola snub

By Fiston Mahamba GOMA, Democratic Republic of Congo (Reuters) - Congo's health minister resigned on Monday after being stripped of responsibility for managing the country's Ebola outbreak, potentially paving the way for the introduction of a second vaccine to contain the spreading epidemic. Oly Ilunga has overseen Democratic Republic of Congo's near year-long response to what is the second deadliest Ebola outbreak in history. It has killed more than 1,700 and been declared an international health emergency by the World Health Organization (WHO)

Reuters July 23, 2019 00:08:17 IST
Congo health minister resigns over Ebola snub

Congo health minister resigns over Ebola snub

By Fiston Mahamba

GOMA, Democratic Republic of Congo (Reuters) - Congo's health minister resigned on Monday after being stripped of responsibility for managing the country's Ebola outbreak, potentially paving the way for the introduction of a second vaccine to contain the spreading epidemic.

Oly Ilunga has overseen Democratic Republic of Congo's near year-long response to what is the second deadliest Ebola outbreak in history. It has killed more than 1,700 and been declared an international health emergency by the World Health Organization (WHO).

President Felix Tshisekedi on Saturday appointed a team led by Jean-Jacques Muyembe, the head of Congo's biomedical research institute, to coordinate the government's response in Ilunga's place.

In his resignation letter, the minister criticised a decision to deploy the second vaccine, manufactured by Johnson & Johnson and backed by the WHO.

It has yet to be used on the ground due to Ilunga's objections. It is designed to complement a Merck treatment that has been given to 170,000 people and proved effective.

Ilunga has said the J&J vaccine has not been proved effective and that deploying a second one would confuse people in eastern Congo, where health workers are struggling to overcome widespread misinformation about the haemorrhagic fever as well as sporadic hostility.

J&J has said the vaccine, which has gone through phase 1 trials and been tested on at least 5,000 volunteers, is safe. Its advocates say it could be deployed in areas not yet affected by Ebola in order to create a firewall around the epidemic.

Ilunga said it would be "fanciful to think that the new vaccine proposed by actors who have shown an obvious lack of ethics by voluntarily hiding important information from medical authorities, could have a significant impact on the control of the current outbreak."

It was not immediately clear who he was referring to, but the WHO as well as other international donors including medical charity Medecins Sans Frontieres have publicly supported use of the second vaccine.

A WHO spokesman said the organisation was grateful for Ilunga's leadership and dedication and looked forward to "working closely with the new coordination team as we have with the previous one."

Last week, the organisation labelled the outbreak an international emergency, a rare designation aimed at galvanising global support as it threatens to gain a foothold in neighbouring Rwanda and Uganda.

Only the 2013-16 epidemic in West Africa that killed more than 11,000 people has been deadlier.

(Reporting by Fiston Mahamba and Anna Pujol-Mazzini; Additional reporting by Kate Kelland in London and Tom Miles in Geneva; Writing by Aaron Ross; Editing by John Stonestreet)

This story has not been edited by Firstpost staff and is generated by auto-feed.

Updated Date:

TAGS:

Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.

also read

Nvidia forecasts strong holiday revenue as pandemic bolsters video game market
Business

Nvidia forecasts strong holiday revenue as pandemic bolsters video game market

By Stephen Nellis and Ayanti Bera (Reuters) - Nvidia Corp forecast fourth-quarter revenue above Wall Street expectations on Wednesday, betting on robust demand for its graphic chips for gaming devices and data centers. Nvidia also beat revenue expectations for the third quarter as gaming business revenue jumped 37% to $2.27 billion (£1.71 billion) from a year earlier, beating FactSet estimates of $2.06 billion. The pandemic "continues to affect our business in both positive and negative ways," Chief Financial Officer Colette Kress said in a statement

Nvidia forecasts fourth-quarter revenue above expectations
Business

Nvidia forecasts fourth-quarter revenue above expectations

(Reuters) - Nvidia Corp forecast fourth-quarter revenue above Wall Street expectations on Wednesday, betting on robust demand for its graphic chips for gaming devices and data centers. The chipmaker said it expects current-quarter revenue of $4.80 billion (£3.61 billion), plus or minus 2%, compared with analysts' average estimate of $4.42 billion, according to IBES data from Refinitiv